Silk Road Medical Inc (NASDAQ: SILK ) posted Q2 revenue of $33.2 million , an increase of 25% Y/Y, driven primarily by increased TCAR adoption, beating the consensus of $31.16 million. "We expanded our FDA label and Medicare coverage for the use of TCAR in standard surgical risk patients, formally … Full story available on Benzinga.com
The following slide deck was published by Silk Road Medical, Inc in conjunction with their 2022 Q2 earnings call.
SUNNYVALE, Calif., July 26, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months ended June 30, 2022.
Silk Road Medical (NASDAQ: SILK ) is set to give its latest quarterly earnings report on Tuesday, 2022-07-26. Here''s what investors need to know before the announcement. Analysts estimate that Silk Road Medical will report an earnings per share (EPS) of $-0.46. Silk Road Medical bulls will hope to hear the company to announce they''ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, … Full story available on Benzinga.com
Silk Road Medical shows rising price performance, earning an upgrade to its IBD Relative Strength Rating.
We see a lack of forward upside capture in Silk Road Medical (SILK), mitigating its inclusion in long-only equity portfolios. See why we remain neutral on SILK.
SUNNYVALE, Calif., July 12, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the second quarter 2022 after market close on Tuesday, July 26, 2022. Company management will host a corresponding audio webcast beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Citigroup downgraded medical device company Silk Road Medical (SILK) to Sell from Neutral in a research note issued on Monday. The firm has a price target of $33, implying a downside…
Silk Road Medical Inc (NASDAQ:SILK) shares, rose in value on Friday, 06/24/22, with the stock price up by 1.17% to the previous day’s close as strong demand from buyers drove the stock to $39.63. Actively observing the price movement in the last trading, the stock closed the session at $39.17, falling within a range of … Silk Road Medical Inc (NASDAQ: SILK): Is It Stable And Growing? Read More »